U.S. market Closed. Opens in 1 day 2 hours 47 minutes

ACST | Acasti Pharma Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-02-292015-02-282014-02-282013-02-282012-02-292011-02-282010-02-28
RevenueN/AN/AN/A196.00KN/AN/AN/AN/A27.79K216.29K450.16K707.39K127.11K29.04KN/A
Cost of Revenue11.00K52.16M15.59M76.00K2.32M2.33MN/AN/A60.08K187.90K262.30K396.94K5.11KN/AN/A
Gross Profit-11.00K-52.16M-15.59M120.00K-2.32M-2.33MN/AN/A-32.29K28.39K187.86K310.45K122.01K29.04KN/A
Operating Expenses11.30M18.25M15.34M10.84M24.44M32.97M15.25MN/A7.06M9.93M9.89M7.13M6.67M2.47M1.54M
Selling, General & Admin6.67M8.21M9.78M6.66M8.46M4.24M3.12MN/A1.61M4.72M6.03M4.19M3.51M857.75K408.59K
Research & Development4.63M9.97M5.56M4.17M15.97M28.73M12.13MN/A5.45M5.21M3.86M2.94M3.16M1.46M1.12M
Other Operating ExpensesN/A63.00KN/A8.00KN/AN/AN/AN/AN/AN/A00N/A146.87K11.40K
Operating Income-11.31M15.72M-15.59M-10.72M-24.44M-33.71M-15.25MN/A-7.09M-9.91M-9.71M-6.82M-6.55M-2.44M-1.54M
Other Expenses / Income-4.62M-45.63M4.71M-11.26M-11.46M-4.91M-1.40MN/A2.43M8.25M-729.73K85.35K11.98K112.77K11.40K
Before Tax Income-14.63M-51.97M-10.47M-19.68M-25.51M-38.62M-16.65MN/A-4.66M-1.32M-10.44M-6.73M-6.54MN/A-1.53M
Income Tax Expenses-1.78M-9.54M-648.00K-127.00K247.00K5.24M291.15KN/A-2.38M-8.52M-246.40K-41.82K22.40K-12.04K-30.43K
Net Income-12.85M-42.43M-9.82M-19.68M-25.76M-43.86M-16.94MN/A-4.66M-1.32M-10.44M-6.73M-6.54M-2.43M-1.51M
Interest Expenses911.00K67.69M224.00K264.00K247.00K273.37K283.41KN/A1.67K3.24K876.002.62K9.01K1.43K431.00
Basic Shares Outstanding9.53M7.44M6.14M2.47M1.76M6.79M2.19M2.19M222.08K221.20K175.77K151.57K140.06K106.88K45.02K
Diluted Shares Outstanding9.53M7.44M6.14M2.47M1.76M6.79M2.19M2.19M222.08K221.20K175.77K151.57K140.06K106.88K45.02K
EBITDA-11.30M15.85M-19.99M-12.31M-21.83M-30.99M-14.01MN/A-5.27M-7.97M-8.84M-6.12M-5.86M-2.42M-1.53M
EBITDA Margin0.00%0.00%0.00%-6,278.97%0.00%0.00%0.00%0.00%-18,970.38%-3,685.03%-1,963.93%-865.44%-4,608.37%-8,347.51%0.00%
EBIT-13.72M15.72M-10.24M-19.54M-25.27M-38.35M-16.37MN/A-7.04M-9.84M-10.68M-6.77M-6.51M-2.44M-1.54M
EBIT Margin0.00%0.00%0.00%-9,969.90%0.00%0.00%0.00%0.00%-25,329.23%-4,547.97%-2,372.82%-957.27%-5,119.22%-8,393.43%0.00%
Financial Year End2024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-02-292015-02-282014-02-282013-02-282012-02-292011-02-282010-02-28
An error has occurred. This application may no longer respond until reloaded. Reload 🗙